HK Stock Market Move | Goldwind Science & Technology (02208) continues to rise by over 5%, with a 70.84% year-on-year increase in net profit for the first quarter. The company's wind turbine sales have also seen a high increase.
Jinfeng Technology (02208) continued to rise by over 5%, with the stock closing up over 15% yesterday. As of the time of writing, it rose by 5.17% to 5.7 Hong Kong dollars, with a trading volume of 86.55 million Hong Kong dollars.
Goldwind Science & Technology (02208) continued to rise by over 5%, with the stock closing up over 15% yesterday. As of the time of writing, it has risen by 5.17% to reach 5.7 Hong Kong dollars, with a trading volume of 86.55 million Hong Kong dollars.
In terms of news, Goldwind Science & Technology recently announced its financial results for the first quarter of 2025, with operating income of approximately 9.472 billion yuan, a year-on-year growth of 35.72%. Net profit attributable to shareholders of the listed company was approximately 568 million yuan, a year-on-year increase of 70.84%. In addition, the company achieved an external sales capacity of approximately 2.59 GW in the first quarter, a year-on-year increase of 80.2%; by the end of the first quarter, the company had an external order backlog of approximately 48.6 GW, a year-on-year increase of 50.3% and a quarter-on-quarter increase of 7.8%.
A research report by Lyon pointed out that Goldwind Science & Technology had a solid start this year, with a 71% year-on-year increase in net profit in the first quarter, reaching 20% above the bank's and market expectations. Lyon mentioned that the gross profit margin of Goldwind Science & Technology in the first quarter decreased by 3.1 percentage points, continuing the weakness of the fourth quarter of the 2024 fiscal year. The highlight of the performance is that its overseas orders now account for 14% of the total order backlog, indicating that the company is gaining market share in overseas markets. The bank has raised the target price for Goldwind Science & Technology H shares from 6.5 Hong Kong dollars to 6.6 Hong Kong dollars, maintaining an "outperform" rating.
Related Articles

China Securities Co., Ltd.: Investment Outlook for the Vaccine Industry in 2026

What reasons could potentially cause the unexpected appreciation of the US dollar next year in 2026? Pay attention to the possibility of a phase reversal in the economic rhythm in the third and fourth quarters.

"The 'Sky-high Monkey' Returns to CRO, will the 20cm Big Red Pillar sound the charge for Joinn Laboratories (06127) stock price to rebound?"
China Securities Co., Ltd.: Investment Outlook for the Vaccine Industry in 2026

What reasons could potentially cause the unexpected appreciation of the US dollar next year in 2026? Pay attention to the possibility of a phase reversal in the economic rhythm in the third and fourth quarters.

"The 'Sky-high Monkey' Returns to CRO, will the 20cm Big Red Pillar sound the charge for Joinn Laboratories (06127) stock price to rebound?"

RECOMMEND

Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025

Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025

Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025


